Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
0.5201
-0.0230 (-4.23%)
At close: Oct 15, 2026, 4:00 PM EDT
0.5200
-0.0001 (-0.02%)
After-hours: Oct 15, 2026, 7:52 PM EDT
Lucid Diagnostics Stock Forecast
LUCD's stock price has decreased by -56.29% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 5 analysts polled by S&P Global, Lucid Diagnostics stock has a consensus rating of "Strong Buy" and an average price target of $4.00. The average 1-year stock price forecast is 669.08% higher than the current stock price, while the lowest is $2.00 (+284.54%) and the highest is $9.50 (+1,726.57%).
Price Target: $4.00 (+669.08%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Lucid Diagnostics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Buy Maintains $3 | Buy | Maintains | $3 | +476.81% | Oct 1, 2026 |
| Maxim Group | Maxim Group | Buy Reiterates $2 | Buy | Reiterates | $2 | +284.54% | Sep 23, 2026 |
| Ascendiant | Ascendiant | Buy Maintains $9.25 → $9.5 | Buy | Maintains | $9.25 → $9.5 | +1,726.57% | Aug 27, 2026 |
| BTIG | BTIG | Buy Reiterates $2.5 | Buy | Reiterates | $2.5 | +380.68% | Aug 17, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $3 | Buy | Reiterates | $3 | +476.81% | May 14, 2026 |
Financial Forecast
Revenue This Year
6.30M
from 4.71M
Increased by 33.93%
Revenue Next Year
16.71M
from 6.30M
Increased by 165.18%
EPS This Year
-0.24
from -0.43
EPS Next Year
-0.17
from -0.24
EPS and Forward PE are based on non-GAAP adjusted numbers.